- Forums
- ASX - By Stock
- RMD
- Ann: ResMed Announces Results for the Fourth Quarter of FY2023
Ann: ResMed Announces Results for the Fourth Quarter of FY2023, page-184
-
-
- There are more pages in this discussion • 188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$30.49 |
Change
-0.010(0.03%) |
Mkt cap ! $19.32B |
Open | High | Low | Value | Volume |
$30.48 | $30.54 | $30.40 | $16.01M | 527.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 489 | $30.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$30.50 | 480 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 263 | 30.490 |
8 | 1076 | 30.480 |
6 | 677 | 30.470 |
2 | 248 | 30.460 |
3 | 220 | 30.450 |
Price($) | Vol. | No. |
---|---|---|
30.500 | 86 | 3 |
30.510 | 1021 | 3 |
30.520 | 1351 | 6 |
30.530 | 282 | 3 |
30.540 | 1040 | 2 |
Last trade - 10.30am 16/07/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online